TDL's Ambitious Growth Journey
As TDL scales operations and pursues digital transformation, enhanced logistics intelligence becomes essential
Critical Compliance Deadlines Approaching
NHS Carbon Reduction Plans
Requirement: All NHS contract holders must submit comprehensive Carbon Reduction Plans with ongoing reporting
Opportunity: Automated CO2 tracking reduces administrative burden while ensuring compliance
ISO 15189:2022 Mandatory Transition
Requirement: Complete audit trails and digital chain of custody for all specimens
Opportunity: Modern platform provides comprehensive compliance automation from day one
Net Zero or Lose NHS Contracts
Requirement: Demonstrable path to net-zero emissions with quarterly progress reporting
Opportunity: Real-time optimization reduces emissions by 15-25% while cutting costs
TDL's Digital Transformation Opportunity
- AI-powered route optimization reduces costs by 15-25%
- Real-time visibility across entire network
- Dynamic reallocation for STAT specimens
- Predictive analytics for capacity planning
- Automated ISO 15189:2022 workflows
- Digital chain of custody with complete audit trails
- NHS Carbon Reduction Plan automation
- Temperature monitoring and deviation management
- Scalable platform supports rapid expansion
- White-label capabilities for partner labs
- Advanced analytics for data-driven decisions
- Modern APIs enable seamless integrations
The OmnioIQ Solution: Live Platform, Immediate Value
Our platform is operational today—start with route optimization, prove ROI, then scale to full transformation
AI-powered optimization layer that enhances existing operations without disruption
- 15-25% reduction in transport costs through intelligent routing
- Dynamic STAT specimen prioritization
- Real-time visibility dashboard
- Multi-constraint optimization (time, temperature, traffic)
- Automatic learning from historical data
Automated workflows and IoT monitoring to meet ISO 15189:2022 and NHS requirements
- ISO 15189:2022 compliant workflows with complete audit trails
- Automated NHS CRP reporting
- IoT temperature monitoring with real-time alerts
- Digital chain of custody with cryptographic verification
- IATA dangerous goods tracking
- Automated compliance dashboards
Full platform integration with strategic partnership and equity participation opportunities
- Modern, scalable architecture for growth
- Seamless LIMS integration (HSL, internal, partners)
- White-label for TDL's pathology network
- Advanced predictive analytics and BI
- Co-development and roadmap influence
- Potential equity investment in OmnioIQ
Live Platform Overview: Operational Today
OmnioIQ and OmnioDriver are production-ready—see the actual interfaces TDL teams would use
Platform Status: Live & Operational
These are actual screenshots from our production platform—not mockups or prototypes. The optimization engine, driver app, and admin dashboard are fully functional and ready for immediate deployment with TDL's operations.
OmnioIQ Admin Platform
OmnioDriver Mobile App (PWA)
Ready for Immediate TDL Deployment
Platform running live courier operations with real-time optimization and chain of custody tracking
Works on any device—iOS, Android, or desktop browser. No app store approval needed.
RESTful API integrates with DA Systems, LIMS, and any existing TDL infrastructure
Financial Model: Proven ROI with Flexible Terms
Choose between traditional SaaS or strategic partnership—both deliver strong returns
| Model Type | Platform Fee | Annual Cost | Annual Savings | Net Benefit |
|---|---|---|---|---|
| Traditional SaaS | 10-15% of logistics spend | £1.5-2.25M | £2.25-3.75M | £0.75-1.5M profit |
| Partnership Model | 5-8% (with equity participation) | £0.75-1.2M | £2.25-3.75M | £1.5-2.55M profit + equity |
Route Optimization
£2.25-3.75M annual reduction through AI routing, dynamic allocation, and traffic-aware planning. Savings begin immediately upon deployment.
Compliance Protection
Avoid NHS penalties, maintain ISO accreditation, meet 2030 net-zero. Protection value: £500K-2M annually in avoided penalties and retained contracts.
Partnership Upside
Strategic partnership allows TDL to participate in OmnioIQ growth. Potential 3-5x return over 5 years based on UK pathology market adoption.
Why Now? Perfect Timing for Innovation Leaders
Technology maturity, regulatory requirements, and market dynamics create ideal conditions for early adopters
Non-Negotiable Deadlines
December 2025 ISO transition and 2030 net-zero mandates require digital infrastructure now. Early implementation reduces pressure and risk.
Technology Ready Today
OmnioIQ platform is live and operational—not vaporware. Start pilot in weeks with real optimization and immediate results.
Market Leadership
TDL's scale and reputation position you to shape UK pathology standards. First-mover advantage creates sustainable competitive moat.
Partnership Window
Strategic partners join pre-scale for equity participation and preferred terms. These opportunities close once Series A funding completes.
Competitive Pressure
Smaller labs are digitizing. NHS increasingly favors technology-enabled providers with demonstrable efficiency and compliance capabilities.
De-Risked Approach
Phased implementation means minimal upfront investment. Prove ROI at each stage with option to pause or continue based on results.
Implementation Roadmap: Clear Milestones, Proven Results
Defined success criteria and decision gates at each stage ensure controlled, low-risk deployment
Proof of Concept
Scope: 5-10 London routes for controlled testing with baseline comparison
Integration: Read-only API layer—no operational disruption
Success: 20% efficiency improvement, sub-5% error rate
Investment: Zero platform fees during pilot
London Operations Rollout
Scope: All London operations (60-80 routes) with full optimization
Features: STAT prioritization, temperature alerts, analytics
Success: £150K+ monthly savings, 99.5% uptime SLA
Compliance Integration
Scope: ISO workflows, NHS reporting, IoT sensors
Deliverables: Audit trails, automated CRP, temperature monitoring
Success: ISO audit-ready, zero compliance findings
Strategic Partnership Evaluation
Assessment: Comprehensive performance review and ROI analysis
Options: Continue SaaS, equity partnership, white-label expansion
Co-Development: Medical logistics features, NHS compliance
Ready to Lead UK Pathology Digital Transformation?
Let's prove the value together with a no-risk pilot program
- 2-day technical workshop with integration planning
- 3-month pilot on 5-10 routes with baseline comparison
- Weekly performance reviews with KPI dashboards
- Zero platform fees during pilot phase
- Cancel anytime if ROI targets not achieved
What We Need from TDL to Begin:
Mutual Value Creation Through Partnership
Strategic partnership goes beyond transactional SaaS relationship
For TDL: Strategic Advantages
Risk Mitigation
Start with low-risk optimization overlay. Prove ROI before full commitment. Maintain complete operational continuity—no disruptive replacement.
Competitive Edge
First-mover advantage in digital medical logistics. Meet ISO 15189:2022 ahead of deadline. Position as innovation leader in UK pathology.
Financial Returns
Immediate savings (£2-3M annually Phase 1). Equity upside as strategic partner. New revenue from white-label services to partner laboratories.
For OmnioIQ: Market Validation
Flagship Reference
TDL's reputation validates platform for UK pathology market. Reference customer for NHS contracts. Real-world proof at Europe's largest scale.
Domain Expertise
Learn from 30+ years TDL operational excellence. Co-develop medical-specific features. Direct access to compliance requirements and regulatory landscape.
Growth Catalyst
£1.5-2.25M ARR from strategic partnership. Opens entire UK pathology market (80+ laboratories). Potential investment partner for Series A.